- Home
- PEBO vs PVLA Comparison
PEBO vs PVLA Comparison
Compare PEBO & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PEBO | PVLA |
|---|---|---|
| Founded | 1902 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PEBO | PVLA |
|---|---|---|
| Price | $31.33 | $97.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 16 |
| Target Price | $34.58 | ★ $124.25 |
| AVG Volume (30 Days) | 150.0K | ★ 257.9K |
| Earning Date | 01-20-2026 | 11-11-2025 |
| Dividend Yield | ★ 5.42% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.86 | N/A |
| Revenue | ★ $555,347,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.07 | N/A |
| P/E Ratio | $10.59 | ★ N/A |
| Revenue Growth | ★ 10.92 | N/A |
| 52 Week Low | $26.21 | $11.17 |
| 52 Week High | $35.32 | $106.71 |
Technical Indicators
Market Signals| Indicator | PEBO | PVLA |
|---|---|---|
| Relative Strength Index (RSI) | 67.28 | 59.76 |
| Support Level | $30.14 | $90.09 |
| Resistance Level | $30.60 | $103.00 |
| Average True Range (ATR) | 0.58 | 6.76 |
| MACD | 0.17 | -0.29 |
| Stochastic Oscillator | 94.60 | 45.36 |
Price Performance
Historical ComparisonAbout PEBO Peoples Bancorp Inc.
Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.